
Sign up to save your podcasts
Or
In this episode, Kristen Mittal and Mridul Mittal at Mittal Consulting and Duane Mancini discuss their unique backgrounds in medtech, why they started Mittal Consulting, what medtech companies should expect from a regulatory strategy report, breakthrough designation, 513(g) vs. pre-submission meetings, common pitfalls, their advice for entrepreneurs, and so much more.
Kristen Mittal LinkedIn
Mridul Mittal LinkedIn
Mittal Consulting LinkedIn
Mittal Consulting Website
Duane Mancini LinkedIn
Project Medtech LinkedIn
Project Medtech Website
5
2323 ratings
In this episode, Kristen Mittal and Mridul Mittal at Mittal Consulting and Duane Mancini discuss their unique backgrounds in medtech, why they started Mittal Consulting, what medtech companies should expect from a regulatory strategy report, breakthrough designation, 513(g) vs. pre-submission meetings, common pitfalls, their advice for entrepreneurs, and so much more.
Kristen Mittal LinkedIn
Mridul Mittal LinkedIn
Mittal Consulting LinkedIn
Mittal Consulting Website
Duane Mancini LinkedIn
Project Medtech LinkedIn
Project Medtech Website
67 Listeners
47 Listeners
57 Listeners
91 Listeners
9,135 Listeners
56,025 Listeners
9,552 Listeners
20 Listeners
17 Listeners
9,042 Listeners
7 Listeners
7 Listeners